A Dose of Reality: How 20 Years of Incomplete Physics and Dosimetry Reporting in Radiobiology Studies May Have Contributed to the Reproducibility Crisis.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 12 03 2019
revised: 20 06 2019
accepted: 29 06 2019
pubmed: 10 7 2019
medline: 15 2 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

A large proportion of preclinical or translational studies using radiation have poor replicability. For a study involving radiation exposure to be replicable, interpretable, and comparable, its experimental methodology must be well reported, particularly in terms of irradiation protocol, including the amount, rate, quality, and geometry of radiation delivery. Here we perform the first large-scale literature review of the current state of reporting of essential experimental physics and dosimetry details in the scientific literature. For 1758 peer-reviewed articles from 469 journals, we evaluated the reporting of basic experimental physics and dosimetry details recommended by the authoritative National Institute of Standards and Technology symposium. We demonstrate that although some physics and dosimetry parameters, such as dose, source type, and energy, are well reported, the majority are not. Furthermore, highly cited journals and articles are systematically more likely to be lacking experimental details related to the irradiation protocol. These findings show a crucial deficiency in the reporting of basic experimental details and severely affect the reproducibility and translatability of a large proportion of radiation biology studies.

Identifiants

pubmed: 31288053
pii: S0360-3016(19)33445-5
doi: 10.1016/j.ijrobp.2019.06.2545
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-252

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Emily Draeger (E)

Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; Department of Therapeutic Oncology, Yale University School of Medicine, New Haven, Connecticut.

Amit Sawant (A)

Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; Division of Medical Physics, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.

Christopher Johnstone (C)

Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.

Brandon Koger (B)

Department of Radiation Oncology, University of Washington, Seattle, Washington.

Stewart Becker (S)

Division of Medical Physics, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.

Zeljko Vujaskovic (Z)

Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; Division of Clinical Programs, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.

Isabel-Lauren Jackson (IL)

Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.

Yannick Poirier (Y)

Division of Translational Radiation Sciences, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; Division of Medical Physics, Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: yannick.poirier@umm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH